Chargement en cours...
Rapamycin versus Methotrexate in Early Diffuse Systemic Sclerosis: Results from a Randomized, Single-blind Pilot Study
OBJECTIVE: To assess the safety and efficacy of rapamycin (RAPA) in the treatment of diffuse systemic sclerosis (SSc) METHODS: Eighteen patients with ≤5 years of diffuse SSc were randomized to receive RAPA or methotrexate (MTX) in a single-blind, 48-week study. Abnormalities in clinical and laborato...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2841149/ https://ncbi.nlm.nih.gov/pubmed/19950289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.24986 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|